Literature DB >> 30088570

[Thirty years of history in the Brazilian Unified National Health System (SUS): a necessary but insufficient transition].

Ligia Bahia1.   

Abstract

This article describes changes in the public, nonprofit, and private components of the health care networks and health insurance and health plan companies in Brazil, based on the accumulated knowledge concerning the gains and obstacles in the Brazilian Unified National Health System (SUS) and differences between policies for democratization and democratizing processes. This central premise allowed analyzing praise versus criticism for the SUS and the contemporary nature of relations between the public and private sectors, drawing on secondary data from agencies in the Executive, Legislative, and Judiciary branches. The article concludes that the highly financialized private and private-charitable sectors imposed anti-democratic and anti-democratizing standards in the use of public funds. The article further concludes that although these sectors have not raised barriers to certain public policies for the expansion of access, they nevertheless prevent the development of the SUS according to the principles set out in the 1988 Constitution.

Mesh:

Year:  2018        PMID: 30088570     DOI: 10.1590/0102-311X00067218

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  3 in total

1.  The everyday political economy of health: community health workers and the response to the 2015 Zika outbreak in Brazil.

Authors:  João Nunes
Journal:  Rev Int Polit Econ       Date:  2019-06-27

2.  An evaluation of Brazil's surveillance and prophylaxis of canine rabies between 2008 and 2017.

Authors:  Julio A Benavides; Jane Megid; Aline Campos; Silene Rocha; Marco A N Vigilato; Katie Hampson
Journal:  PLoS Negl Trop Dis       Date:  2019-08-05

Review 3.  Litigation to Access Health Services: Ally or Enemy of Global Public Health?

Authors:  Alexandre Martins; Sydney Allen
Journal:  Ann Glob Health       Date:  2020-02-07       Impact factor: 2.462

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.